Assertio (ASRT)
(Delayed Data from NSDQ)
$1.54 USD
-0.12 (-7.23%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $1.55 +0.01 (0.65%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
ASRT 1.54 -0.12(-7.23%)
Will ASRT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ASRT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ASRT
Revolution Medicines (RVMD) Moves 11.0% Higher: Will This Strength Last?
Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why
ASRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Other News for ASRT
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Assertio: An Extremely Asymmetric Bet Skewed To The Upside
Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
Sidoti Events, LLC's Virtual June Small-Cap Conference
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying